TB Drugs Flashcards
What are the 4 TB drugs used for patient with active TB
Rifampicin, isoniazid, pyrazinamide and Ethambutol (if cannot then steptomycin)
Are they concentration dependent or time dependent killing?
Concentration dependent killing
Rifampicin class and MOA
It inhibits the RNA synthesis of RNA polymerase.
Isoniazid MOA
It Inhibits the mycolic acid synthesis (within the cell wall).
Ethambutol MOA
Inhibit cell wall synthesis
Pyrazinamide MOA
Inhibit cell membrane synthesis
Streptomycin MOA
Inhibits the protein synthesis by targeting the 30s ribosomal subunit.
Rifampicin adverse effects
- Skin eruptions, fever, GIT disturbances.
- Hepatitis, hyperbilirubinemia, and transaminasaemia
- Hepatoxicity
- Immunologically-mediated reactions: thrombocytopenia
flu-like syndrome (usually low doses of intermittent rifampicin)
PTB drugs inhibitors and inducers
- INH- inhibit CYP2C19,3A4,2D6, 2E1
- RIF- induces CYP1A2,2C9, 2C19, 3A4 and P-glycoprotein.
Rifampicin DDI
- warfarin (RIF inducer of warfarin)
- HIV protease inhibitors
- most non-nucleoside reverse
transcriptase inhibitors (nNRTIs) - oral contraceptives
- INH or pyrazinamide (increase hepatotoxicity)
- Methadone (opioid agonists)
Isoniazid pK PD in indian and chinese
Indian- slow acetylators
Chinese-fast acetylators.
Isoniazid Adverse Effect
- Allergic skin reactions
- Hepatotoxicity
- Neurotoxic effects
- Can cause pellagra
- Haemolysis in G6PD patients
Isoniazid DDI
- phenytoin (ISH- inhibitor)
- Carbamazepine (ISH- inhibitor)
- rifampicin or pyrazinamide (increase risk of hepatotoxicity)
- Alcohol intake(increase risk of hepatotoxicity)
- Aluminium salts (reduce absorption)
Pyrazinamide adverse effects
- hepatotoxicity (1-5%) – primary adverse effect; it is dose-related, with a fatality
rate as high as 1%. - GIT - nausea, vomiting
- rashes, photosensitivity
- arthralgia (JOINT STIFFNESS)
- Hyperuricaemia: its metabolite, pyrazinoic acid, interferes with the tubular
secretion of uric acid; mostly asymptomatic, but (rarely), can cause acute gouty
arthritis.
Pyrazinamide DDI
rifampicin - increase hepatotoxicity
Ethambutol: Adverse effects
- Most significant - optic neuritis, with visual abnormality (1-2%). Symptoms of
visual toxicity: reduced visual acuity, red/green colour blindness
Best avoided in children < 8 years who may not be able to co-operate in an eye
test. - GIT – diarrhoea
- Allergic rash
- Asymptomatic hyperuricaemia, occasional gouty arthritis (due to inhibition of
uric acid secretion)
Ethambutol DDI
Aluminum salts (antacids) (reduce absorption)
When to start TB treatment?
- CXR suggestive of active TB
- TB treatment can be started
prior to sputum results
returning
– Public health point of view
- Baseline tests:
– Eye: Colour vision and Visual
acuity
– AST/ALT/Creatinine
– HIV,DM (f.glucose / HbA1c)
Duration of TB treatment
TB meningitis: 12 months, with adjunctive steroids
* TB pericarditis: 6 months, with adjunctive steroids
* Musculoskeletal TB: 9 months
* Lymph node: 6-9 months
* Pleural TB: 6-9 months
how to order TB drug?
Weigh patient!
* Rifampicin (Rif):
– 10 mg/kg. Round UP
* Isoniazid (INH) : (beware the underweight patient)
– 5 mg/kg. Round down
* Ethambutol (EMB):
– 20 mg/kg (first two months), round down.
– If need EMB beyond 2 months, dose 15mg/kg, round down
* Pyrazinamide (PZA) (omit if Age > 65)/cirrhotic):
– 25 mg/kg, round down.
* B6: 10 mg om.
* Maximum Limits (regardless of weight):
– EMB 1.6 g om
– PZA 2 g om.
Patient education of TB drugs
Rifampicin 1. Imparts a harmless orange color to urine,
sweat, and tears (soft contact lenses may
be permanently stained)
2. Skin eruptions, fever and GIT disturbances
are the most common side effects.
3. Alcohol intake
Isoniazid 1. Take pyridoxine when taking INH to prevent
pellagra
2. For breastfeeding moms, INH can pass
through breastmilk
3. Reduce alcohol intake
4. Tingling sensations (neuropathy)
Pyrazinamide 1. Use sunscreen
2. Alcohol intake
Ethambutol 1. Watch for visual changes
Hepatotoxicty in TB drugs, and how to manage
If latent TB: Stop treatment immediately
▪ Monitor LFTs
▪ Re-challenge with INH
when ALT improves to < 2x ULN
▪ If patient can’t tolerate INH, switch to
RIF x 4 months
Patient with symptoms of hepatitis:
If Active TB:
Stop all TB drugs and perform LFTs:
a) AST or or bilirubin ≥ 3 times upper limit of normal (ULN)or ALT>5x ULN : wait for resolution of symptoms, perform LFTs weekly and restart TB treatment when LFTs are < 3 times ULN.
b) AST, ALT and bilirubin < 3 times ULN and mild symptoms (no jaundice): restart TB treatment, closely monitor the patient and perform LFTs weekly. Continue TB treatment as long as LFTs levels remain < 3 ULN and there are no signs of worsening hepatitis.
Restart RIF
restart INH 3-7 days later
restart PZA 7 days later
EMB may be restarted anytime
▪ May need non-hepatotoxic regimen: EMB
+ FQ + streptomycin
If still cannot then use this 9 month regime:
For patients who are unlikely to tolerate pyrazinamide (e.g. the elderly, those with liver disease), a 9-month regimen comprising ethambutol, rifampicin and isoniazid for 2 months followed by rifampicin and isoniazid for 7 months may be used.
Important guidelines and education for patients on TB drugs
The patient’s weight should be documented at each
visit and the drug dosages adjusted accordingly. Adult
patients on ethambutol must have their visual acuity
and colour vision checked at each visit. Those with
risk factors for drug-induced hepatitis must be closely
monitored